Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
about
MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11The IkappaB kinase complex: master regulator of NF-kappaB signalingSimvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson's diseaseNeuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent PerspectivesChronic Stress and Glucocorticoids: From Neuronal Plasticity to NeurodegenerationNF-kappaB Signaling Pathways in Neurological Inflammation: A Mini ReviewInnate Immune Response in Brain, NF-Kappa B Signaling and CystatinsNeuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugsNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunitySodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's diseasePossible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disordersAnkyrin repeat and BTB/POZ domain containing protein-2 inhibits the aggregation of alpha-synuclein: implications for Parkinson's diseaseA phase I clinical trial of systemically delivered NEMO binding domain peptide in dogs with spontaneous activated B-cell like diffuse large B-cell lymphomaInhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicityIKKalpha and IKKbeta regulation of DNA damage-induced cleavage of huntingtin.Morin exerts neuroprotective actions in Parkinson disease models in vitro and in vivo.Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease modelOral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing miceMyelin basic protein priming reduces the expression of Foxp3 in T cells via nitric oxide.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses.Enhancement of morphological plasticity in hippocampal neurons by a physically modified saline via phosphatidylinositol-3 kinase.A physically-modified saline suppresses neuronal apoptosis, attenuates tau phosphorylation and protects memory in an animal model of Alzheimer's disease.Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases.MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA.Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson's disease.Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease.Cell penetrating peptide inhibitors of nuclear factor-kappa B.Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2.Does Huntingtin play a role in selective macroautophagy?Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonismTranscriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy.Prospects of statins in Parkinson diseaseInflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65Can cinnamon bring aroma in Parkinson's disease treatment?Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia.Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling.Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism
P2860
Q24289060-29907D45-7E7F-4F5D-970D-BE6599862940Q24313366-5925F7D9-34CE-4B5D-BC1E-18BECAAAF07BQ24629942-F753F9B2-FDE2-48A7-91B1-F7D84B9F2689Q26747508-0CF4693B-D3B7-4F48-A236-34E6AC05528EQ26748974-10C434BC-E2AA-4920-8E99-BD1CE18C7AB1Q26770760-3922F50B-BA56-473F-8E7D-97FB0796ED83Q26773162-0B05D2DB-84E4-48AC-84C0-9D830BD9FAF2Q26801035-97E58DE0-2D20-4887-AC8E-95CD076D22CBQ27027973-96532B37-3D80-446E-99C0-E19AB1B854F0Q27301885-C2B10824-7299-4086-854E-05E13A49B395Q28386662-1A24C476-6953-43BF-ADA9-C984F59CDAFFQ28505185-F4389786-3AB1-4D9D-8DA7-6EE9AB0897BDQ28538467-16B186AA-9BF1-4A59-B924-81C387A3E7BFQ28577454-4EA4CA08-0BE7-4334-8C3C-E83F2128917EQ33458331-4B7B4C1A-644F-4452-A9C8-565E268788CFQ33557852-A3BAFE15-E874-4188-865F-7B5908E931D9Q33608424-C200553D-6F98-4C6F-B40F-88D93BDB18E2Q33680232-1A515EBE-D915-425E-A67F-6EA11BDD8476Q33793585-3752447F-323E-4463-963D-E5B3C7AB56B6Q33795121-D257C82A-042E-40F3-B16D-1E28533F8A06Q33797938-81A869E9-F53C-4209-8DFC-96D15DDD3D06Q33822381-ABE39DE2-0C4B-4B5C-A09F-6BE88EEFD127Q33875311-200668BE-5EF0-45D3-BDA0-42BBD2CF9C09Q33999486-CF0EA38B-7AF6-4CDF-9EC2-DD2E905ACBEDQ34027672-C8F834B6-18D9-4501-8EE8-181C76354114Q34197681-8E07C31E-36A4-4A8A-87AC-D0355E848765Q34205454-1F4A00E6-37F2-465F-A8D8-EC61A65BEF47Q34287439-C29324A0-1830-4E1C-8159-9F4F6E74DA50Q34289086-9FFB747C-4836-4C88-9891-4BED4BBD5252Q34570989-01FC6776-8F51-4E14-87C0-98FDEBE6F848Q34618914-19993C68-FE4C-4F43-8985-6DDEFF7A6897Q34835467-9A6AA629-FE90-461D-A058-5DA08C532BBFQ34983243-55A697E8-8B48-4970-9D22-971599364EBAQ35016939-3236BDFC-65B9-4471-8A9B-6FB1604C290DQ35094028-9DBC60B4-6963-4A3D-8016-622568C72597Q35121810-B54F84F1-1371-4B9B-B6A0-51FCFEF108A3Q35169915-A278EC91-A9F5-43E2-B764-448782957352Q35227444-D02161BC-840D-47B6-B2DC-3357F3F4EEBFQ35386499-7D674EE6-740F-4CE5-9511-176F496B8B44Q35587423-8FE73DE9-532C-482F-8F9D-359D011F473B
P2860
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@ast
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@en
type
label
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@ast
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@en
prefLabel
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@ast
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@en
P2093
P2860
P921
P356
P1476
Selective inhibition of NF-kap ...... e model of Parkinson's disease
@en
P2093
Anamitra Ghosh
Dean M Hartley
Elliott J Mufson
Howard E Gendelman
Kalipada Pahan
R Lee Mosley
Sankar Ghosh
Xiaojuan Liu
P2860
P304
18754-18759
P356
10.1073/PNAS.0704908104
P407
P577
2007-11-13T00:00:00Z